Yukihiro Shiraki

12PUBLICATIONS
75CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Feb 06, 2026
Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation.

Kaname Uno, Masato Yoshihara, Yoshihiko Yamakita

|Dec 16, 2025
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

Xingxing Wang, Keiko Shinjo, Kohei Kumegawa

|Oct 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Nobutoshi Esaki, Tomoka Sakoda, Ryota Ando

|May 03, 2025
Pathological changes of a malignant liver tumor after systemic therapies.

Shinya Kuwabara, Yugo Kinoshita, Yuichi Koshiyama

Pageof 2

Frequent Collaborators

8 joint publications

Atsushi Enomoto

4 joint publications

Shinji Mii

3 joint publications

Tomoe Kobayashi

2 joint publications

Masahide Takahashi